|
Historical
Information on Atypical Antipsychotic Drugs
Aripiprazole (marketed as Abilify); Clozapine (marketed as Clozaril); Olanzapine (marketed as Zyprexa); Olanzapine/Fluoxetine (marketed
as Symbyax);
Quetiapine (marketed as Seroquel);
Risperidone (marketed as
Risperdal); Ziprasidone (marketed as Geodon);
-
Public Health Advisory
(4/11/2005)
-
FDA Talk Paper (4/11/2005)
-
Healthcare Professional Sheets.
-
Aripiprazole (marketed as Abilify)
[PDF] [HTML]
9/2006:
The issue described in this alert has been
addressed in product labeling.
-
Clozapine (marketed as Clozaril)
[PDF] [HTML]
9/2006:
The issue described in this alert has been
addressed in product labeling.
-
Olanzapine (marketed as Zyprexa)
[PDF] [HTML]
9/2006:
The issue described in this alert has been
addressed in product labeling.
-
Olanzapine/Fluoxetine (marketed
as Symbyax) [PDF]
[HTML]
9/2006: The issue described in the 4/11/2005 alert has been
addressed in product labeling.
-
Quetiapine (marketed as Seroquel)
[PDF] [HTML]
9/2006: The issue described in
this alert has been addressed in product labeling.
-
Risperidone (marketed as
Risperdal) [PDF]
[HTML]
9/2006:
The issue described in this alert has been addressed in product
labeling.
-
Ziprasidone (marketed as Geodon)
[PDF] [HTML]
9/2006:
The issue described in this alert has been
addressed in product labeling.
 Back
to Top 
Back to Atypical
Antipsychotic Drugs
PDF requires the free Adobe
Acrobat Reader
Date created: September 6, 2006 |
